Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2017

Feb 1, 2017

29745_dirs_2017-01-31_144445aa-ee7a-49de-b0d6-c1cc702c9bc6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-01-27

Reporting Person: Zulueta Alfonso G (SVP& Pres., Emerging Markets)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-27 Common Stock A 13150 $75.38 Acquired 57051 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-01-27 Restricted Stock Unit $ A 15993 Acquired 2018-02-01 Common Stock (15993.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4288 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.